<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201973/" ref="ordinalpos=586&amp;ncbi_uid=3319970&amp;link_uid=PMC3201973" image-link="/pmc/articles/PMC3201973/figure/pone-0026766-g009/" class="imagepopup">Figure 9. PIC treatment inhibits the EGF-Shh-mediated Ras-ERK <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in primary cortical neurospheres..  From: Toll-like Receptor 3 Regulates Neural Stem Cell Proliferation by Modulating the Sonic Hedgehog <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">Shh binds to the cell surface receptor Ptch, relieves the inhibition of Smo and triggers Shh signaling. Activation of the Shh pathway results in increased levels of Gli1 expression and activation of the downstream Ras-MEK-ERK pathway, causing cell proliferation. In WT neurospheres cultured in the presence of EGF, PIC signals via TLR3 to inhibit Gli1 expression and interfere with MEK and ERK phosphorylation. Inhibition of MEK-ERK activation results in the decreased proliferation and induced Fas expression and apoptosis observed after PIC treatment of primary cortical neurospheres.</div></div>